Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hCG for Breast Cancer Prevention
NCT00808522Phase 3Unknown
- Sponsor
- NewYork-Presbyterian Hospital
- Start
- Dec 2008
- Primary completion
- Dec 2009
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human chorionic gonadotrophin in breast cancer, sponsored by NewYork-Presbyterian Hospital. Status: unknown.
02
Drugs
recombinant human chorionic gonadotrophin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00808522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808522.